$ISRG is back in focus as competition in surgical robotics heats up and investors reassess the company’s growth outlook. Intuitive still has a huge installed base and strong demand for its da Vinci systems, while newer platforms and international expansion could provide additional growth. But rising competition and slower U.S. procedure growth are giving investors more to think about. After the recent sell-off, the big question is whether this is a temporary reset or the start of a bigger challenge to Intuitive’s dominance. Do you think $ISRG is a buying opportunity here, or is competition becoming a bigger risk?